Meeting
2015 ASCO Annual Meeting
Comprehensive characterization of cisplatin-related hearing loss in U.S. and Canadian Testicular Cancer Survivors (TCS).
Authors
Heather E. Wheeler
Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
Heather E. Wheeler , Lois B. Travis , Amy Budnick , Darren Richard Feldman , Lawrence H. Einhorn , Robert James Hamilton , David J. Vaughn , Clair Beard , Chunkit Fung , Eileen Johnson , Malcolm J. Moore , Deepak M. Sahasrabudhe , Sophie D. Fossa , Howard D. Sesso , M. Eileen Dolan , Robert D Frisina
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Survivorship
Citation
J Clin Oncol 33, 2015 (suppl; abstr 9570)
DOI
10.1200/jco.2015.33.15_suppl.9570
Abstract #
9570
Poster Bd #
229
Abstract Disclosures
Similar Posters
Poster
2012 Genitourinary Cancers Symposium
Association of GSTP1, COMT, and TPMT with testicular cancer (TC) treatment outcome after cisplatin-based chemotherapy (CBCT).
First Author: Chunkit Fung
Poster
2017 ASCO Annual Meeting
Clinical, sociodemographic, and behavioral factors associated with cumulative burden of morbidity (CBM) among testicular cancer survivors (TCS) in the Platinum study.
First Author: Sarah L. Kerns
Poster
2022 ASCO Annual Meeting
Impact of adverse health outcomes (AHOs) on self-reported physical and mental health in U.S. testicular cancer survivors (TCS).
First Author: Paul C. Dinh Jr.
Poster
2021 ASCO Annual Meeting
Factors associated with use of medications for anxiety and depression in testicular cancer survivors after cisplatin-based chemotherapy.
First Author: Shirin Ardeshirrouhanifard